Johnson & Johnson CEO Alex Gorsky has been elected chairman of the board for the company, Bloomberg reports. He will replace Bill Weldon, who stepped down as CEO in April and is retiring next year.
Weldon had been in charge during some prominent missteps for the company, including a string of recalls.
An all-metal artificial hip manufactured by Johnson & Johnson subsidiary DePuy Orthopaedics was recalled in 2010 after a number of ...
continue reading...The U.S. Food and Drug Administration has issued a warning that the hepatitis C drug Incivek, manufactured by Vertex Pharmaceuticals Inc., can cause serious and potentially deadly skin reactions.
Vertex has placed a “black box warning” – the most serious available – on the drug’s label, Reuters reports.
According to the Reuters story, skin rashes were already a known side effect of the drug. The warning came in response to an analysis of data collected since the drug was approved in the ...
continue reading...
A Bloomberg report says German pharmaceutical company Boehringer Ingelheim GmbH is now facing more than 150 lawsuits over claims that the company sold the blood thinner Pradaxa despite being aware that it could cause potentially deadly bleeding.
Plaintiffs’ lawyers say the company will probably end up facing thousands more lawsuits in coming years. According to the story, the drug has been linked to ...
continue reading...
CBS News out of Detroit reports on an $8 million settlement in the case of a woman who alleges she was denied proper care when she gave birth in jail, and her daughter suffered brain damage as a result.
According to the report, Chantrienes Barker went into labor while she was jailed in Wayne County, Mich., in1998. Although she was taken to a hospital, she was ...
continue reading...
The European Commission has approved a diabetes medicine that U.S. regulators have rejected, Reuters reports.
The medication, by Bristol-Myers Squibb Co and AstraZeneca Plc, is called Forxiga. It’s part of a new class of diabetes drugs that work independently of insulin to control blood sugar.
Its manufacturers are touting Forxiga’s capacity for lowering blood pressure and inducing weight loss. But when regulators with the U.S. Food and Drug Administration rejected it in ...
continue reading...
A Baltimore jury awarded a couple $55 million damages, over their claims that Johns Hopkins Hospital’s negligence resulted in their son being born with severe mental and physical disabilities.
A story in the Baltimore Sun says it was one of the largest malpractice judgments in Maryland history.
The mother, Rebecca Fielding, had wanted to deliver her baby at home with the assistance of a midwife, the story ...
continue reading...
